Critical Illness launched
Essential medicines information to support complex decision-making and dynamic prescribing in critical care
Pharmaceutical Press, the Royal Pharmaceutical Society’s knowledge business has announced the launch of Critical Illness, essential drug information supporting the critical care multi-disciplinary team. Available on subscription through MedicinesComplete from January 2021, Critical Illness supports complex decision-making and dynamic prescribing in critical care.
Authored using a variety of resources including primary literature, the information is based on the clinical practice and expertise of the editors-in-chief, editors and contributors who are highly experienced critical care specialists.
Regularly updated, this essential resource provides dosing guidance and required adjustments, administration advice, pharmacokinetic and pharmacodynamic information as well as other important patient considerations. It was developed with contributions from a large number of UK pharmacists and intensivists, including quite a few of our Pharmacy Sub-Committee Members.
The Editors-in-Chief, Dr Barbara Philips, Greg Barton and Dr Cathrine McKenzie said:
“We are delighted that the first edition of Critical Illness is launching on MedicinesComplete. The vision of a dynamic evidenced-based guide to drugs in critical illness has evolved from an idea into an extensive collaboration with colleagues and friends from over the UK and the international critical care community. It has been our pleasure to work alongside colleagues at Pharmaceutical Press and special thank you to the editors and expert contributors, it would not have been possible without you.”
For more information about Critical Illness go to: about.medicinescomplete.com/publication/critical-illness/